Germany's new conservative government is debating the legalization of cannabis, yet businesses in the sector, particularly Cantourage, are flourishing. With a reported revenue increase of 118% in 2023, Cantourage is addressing the needs of patients by providing cannabis for chronic pain, epilepsy, and palliative care. Despite safety concerns over crime related to cannabis distribution, the company emphasizes high standards for product safety and compliance. The partial legalization, effective since 2017, is fostering a competitive environment for companies to capitalize on the growing demand for medical cannabis.
The company's commitment to safety is paramount as they deal with cannabis products sourced internationally, aiming to maintain the highest standards for both workers and consumers.
Despite pushback from government officials regarding full legalization, the demand for medical cannabis is surging, evidenced by Cantourage's impressive revenue growth over the last year.
Collection
[
|
...
]